Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC

  • 0Department of Laboratory Medicine, School of Medicine, Hunan Normal University, Changsha 410013, China.

|

|

Summary

This summary is machine-generated.

High expression of ubiquitin-specific protease 1 (USP1) promotes bladder cancer progression by stabilizing c-MYC. USP1 may be a new therapeutic target for bladder cancer treatment.

Area Of Science

  • Oncology
  • Molecular Biology
  • Biochemistry

Background

  • Ubiquitination is a critical post-transcriptional modification for cell homeostasis.
  • Ubiquitin-specific protease 1 (USP1), a deubiquitination enzyme, is linked to tumor progression.
  • The role of USP1 in bladder cancer remains largely uncharacterized.

Purpose Of The Study

  • To investigate USP1 expression levels in bladder cancer.
  • To elucidate the functional role of USP1 in bladder cancer progression.
  • To identify potential therapeutic targets for bladder cancer.

Main Methods

  • USP1 expression analysis using GEPIA web server.
  • Construction of USP1-knockout and USP1-overexpressing bladder cancer cell lines (UMUC3, T24).
  • Cellular assays (CCK8, colony formation, Transwell) to assess proliferation and migration.
  • RNA-sequencing and dual-luciferase reporter assays to identify signaling pathways.
  • Co-immunoprecipitation and immunofluorescence to study USP1-c-MYC interaction.
  • In vivo studies using a xenograft mouse model.

Main Results

  • USP1 expression is upregulated in bladder cancer and correlates with poor patient prognosis.
  • USP1 overexpression enhances bladder cancer cell proliferation, clone formation, and migration.
  • USP1 deficiency inhibits tumor growth in vivo.
  • The c-MYC pathway is significantly activated by USP1.
  • USP1 interacts with c-MYC and enhances its stability in a catalytically dependent manner.

Conclusions

  • Elevated USP1 expression drives bladder cancer progression through c-MYC stabilization.
  • USP1 represents a potential novel therapeutic target for bladder cancer treatment.

Related Concept Videos

Induced Pluripotent Stem Cells 01:06

3.9K

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

Abnormal Proliferation 02:23

4.5K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Anaphase Promoting Complex 00:50

2.8K

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...

mTOR Signaling and Cancer Progression 03:03

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Regulated Protein Degradation 02:58

7.2K

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

The Proteasome 01:13

815

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...